NL-OMON50605
Recruiting
Not Applicable
Biomarkers and Mood course in Bipolar disorder in the Netherlands - a Longitudinal Cohort study (BINCO) - BINCO
psychiatrie0 sites210 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- psychiatrie
- Enrollment
- 210
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Diagnosed with bipolar disorder type I and II according the SCID\-I (diagnosis
- •\- Aged above 18 , One of out of 2 criteria below:
- •\- Start of specialized outpatient treatment
- •\- Admission due to depression or mania, Healthy controls:
- •\-matched on age and gender with patient population
Exclusion Criteria
- •\- Current treatment or detention under the Dutch governmental mental health
- •\- Participants that cannot read, speak or understand Dutch.
- •\- Aged below 18
- •\- Diagnosed with bipolar disorder NOS or cyclothymic disorder., For MRI
- •\- Ferrous objects in or around the body (e.g. braces, glasses, pacemaker, metal
- •\- History of closed\- or open\-head injury
- •\- History of neurological illness or endocrinological dysfunction with CNS
- •\- Claustrophobia
- •\- History of epilepsy
- •\- Drug or alcohol abuse over a period of six months prior to the experiment ,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Course and Outcome of Bipolar disorderHealth Condition 1: F31- Bipolar disorderCTRI/2018/12/016547ot applicable
Recruiting
Phase 2
Riluzole in the control of obsession in bipolar patientsIRCT20211118053093N4Shiraz University of Medical Sciences40
Unknown
Not Applicable
Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar DisorderBipolar DisorderNCT04703972University Hospital, Grenoble10
Completed
Not Applicable
Factors leading to Bipolar disorderCTRI/2021/07/035130Kasturba medical college244
Active, not recruiting
Not Applicable
Biomarkers for Pharmacoresponse in Bipolar Disorder - CoagulationNCT06581822Karolinska Institutet68